Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FELQW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,599
Award facts
- Contract value 100% obligated
- $16,599.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,599.01 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 13, 2025, with an ultimate completion date of November 21, 2025, is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. No set-aside designation was applied to this award, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group specializes in distributing a comprehensive range of pharmaceutical products and medical consumables to federal agencies, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical supplies. The parent IDC, awarded November 13, 2025, carries a $499.9 billion ceiling value and extends through December 31, 2036, positioning the company as a critical pharmaceutical supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy. Under this contract structure, the DLA issues delivery orders to support recurring medical supply needs for Department of Defense healthcare facilities worldwide, with DMS Pharmaceutical Group's demonstrated performance on numerous previous orders confirming its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FELQW?
SPE2DU26FELQW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DU26FELQW worth?
The government has obligated $16,599 on SPE2DU26FELQW.
Is contract SPE2DU26FELQW an order under another contract?
Yes. SPE2DU26FELQW is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELQW competed?
The extent of competition for SPE2DU26FELQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award